Literature DB >> 813765

Dissociation and denaturation equilibria and kinetics of a homogeneous human immunoglobulin Fab fragment.

E S Rowe.   

Abstract

The conformational equilibria and the kinetics of the approach to equilibrium of an IgG1 myeloma (Wes) Fab fragment (SSFab) and its mildly reduced and S-carboxyamidomethylated derivative (RAFab) were studied as a function of guanidine hydrochloride concentration. The unimolecular denaturation of SSFab, the bimolecular denaturation of RAFab, and the denaturation of Wes L chain reported previously (Rowe, E. S., and Tanford, C., (1973), Biochemistry 12, 4822) are interpreted in terms of the domain structure and evaluated in terms of the thermodynamic stability of the protein and the covalent and noncovalent interactions among its subunits. The Fd-L interactions are found to be extremely strong and are maintained at concentrations of denaturant sufficient to denature the individual domains. It is shown that all of the data are consistent with a two region structure for Fab, one composed of the vL and vH domains, and the other composed of the cL and cH domains, so that there are two sites of noncovalent Fd-L interactions. One region, identified as the C region, is found to be 10(2)-10(4) times more stable than the other; this difference in stability is attributed largely to a stronger and more extensive interaction between the domains of this region. The kinetics of the approach to equilibrium are found to be extremely slow in the center of the transitions, requiring up to a week for equilibration for RAFab, and several months for SSFab. This unusual kinetic behavior is shown to be due to the strong Fd-L interaction under conditions where the monomeric domains are unstable.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 813765     DOI: 10.1021/bi00649a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Spin Diffusion Editing for Structural Fingerprints of Therapeutic Antibodies.

Authors:  Joshua Franks; John N Glushka; Michael T Jones; David H Live; Qin Zou; James H Prestegard
Journal:  Anal Chem       Date:  2015-12-22       Impact factor: 6.986

2.  Boosting antibody developability through rational sequence optimization.

Authors:  Daniel Seeliger; Patrick Schulz; Tobias Litzenburger; Julia Spitz; Stefan Hoerer; Michaela Blech; Barbara Enenkel; Joey M Studts; Patrick Garidel; Anne R Karow
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Expression studies of catalytic antibodies.

Authors:  H D Ulrich; P A Patten; P L Yang; F E Romesberg; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment.

Authors:  H Lilie; R Jaenicke; J Buchner
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

Review 5.  The problem of the stability globular proteins.

Authors:  W Pfeil
Journal:  Mol Cell Biochem       Date:  1981-10-09       Impact factor: 3.396

6.  Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.

Authors:  P H Tan; B M Sandmaier; P S Stayton
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

7.  The thiol groups of mouse immunoglobulin A. Incomplete formation of the C alpha 1-domain disulphide bridge.

Authors:  S A Cockle; N M Young
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

8.  Cold denaturation of monoclonal antibodies.

Authors:  Kristi L Lazar; Thomas W Patapoff; Vikas K Sharma
Journal:  MAbs       Date:  2010-01-27       Impact factor: 5.857

Review 9.  Modelling of pH-dependence to develop a strategy for stabilising mAbs at acidic steps in production.

Authors:  Max Hebditch; Ryan Kean; Jim Warwicker
Journal:  Comput Struct Biotechnol J       Date:  2020-03-10       Impact factor: 7.271

10.  Sequence composition predicts immunoglobulin superfamily members that could share the intrinsically disordered properties of antibody CH1 domains.

Authors:  Max Hebditch; Robin Curtis; Jim Warwicker
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.